Is HCA Healthcare (HCA) Attractively Priced After Strong 70% One-Year Share Return?

robot
Abstract generation in progress

This article analyzes whether HCA Healthcare (HCA) is attractively priced following a 70% one-year share return. Using a Discounted Cash Flow (DCF) analysis, Simply Wall St estimates an intrinsic value of US$890.18 per share, suggesting HCA is undervalued by 40.2% compared to its current price of US$532.58. Additionally, HCA’s P/E ratio of 17.5x is below both its peer average and the broader Healthcare industry average, further indicating potential undervaluation.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin